UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000041408
Receipt number R000046395
Scientific Title Registry research around the nation for rare and intractable diseases associated with deafblindness
Date of disclosure of the study information 2020/08/17
Last modified on 2022/09/06 12:58:25

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Registry research around the nation for rare and intractable diseases associated with deafblindness

Acronym

Research on deafblindness

Scientific Title

Registry research around the nation for rare and intractable diseases associated with deafblindness

Scientific Title:Acronym

Research for rare and intractable diseases associated with deafblindness

Region

Japan


Condition

Condition

deafblindness

Classification by specialty

Pediatrics Ophthalmology Oto-rhino-laryngology

Classification by malignancy

Others

Genomic information

YES


Objectives

Narrative objectives1

To accumulate background, clinical, and genome information of the patients of rare and intractable diseases associated with deafblindness.

Basic objectives2

Others

Basic objectives -Others

To produce evidences for clinical guidelines, etc. for the diseases of the present study

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Number of patients

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit

99 years-old >=

Gender

Male and Female

Key inclusion criteria

Patients who meet all the criteria below are included in the present study. Relatives of these patients are also included if necessary.
1)Patients who have both vision and hearing impairment
2)Patients who developed both vision and hearing impairment under the age of 40
3)Patients whose vision and hearing impairment may be derived from the same cause
4)Patients from whom consent for participation in the research can be obtained by document

Key exclusion criteria

Patients who meet any of the criteria below are excluded from enrollment in the present study.
1)Patients with vision and hearing impairment which are caused by only environmental factors such as injuries after birth
2)Patients who has vision impairment by common refractive errors and the like which can be corrected by glasses and the like
3)Patients who has hearing impairment by common otitis media and the like which can be recovered
4)Patients who have only age-related vision impairment or hearing impairment
5)Patients who are considered to be inappropriate as the subjects by researches and the like

Target sample size

2600


Research contact person

Name of lead principal investigator

1st name Tatsuo
Middle name
Last name Matsunaga

Organization

National Hospital Organization Tokyo Medical Center

Division name

National Institute of Sensory Organs, Division of Hearing and Balance Research

Zip code

152-8902

Address

2-5-1 Higashigaoka, Meguro, Tokyo 152-8902, Japan

TEL

03-3411-0111

Email

tatsuo.matsunaga@kankakuki.jp


Public contact

Name of contact person

1st name Tatsuo
Middle name
Last name Matsunaga

Organization

National Hospital Organization Tokyo Medical Center

Division name

National Institute of Sensory Organs, Division of Hearing and Balance Research

Zip code

152-8902

Address

2-5-1 Higashigaoka, Meguro, Tokyo 152-8902, Japan

TEL

03-3411-0111

Homepage URL


Email

tatsuo.matsunaga@kankakuki.jp


Sponsor or person

Institute

National Hospital Organization Tokyo Medical Center, National Institute of Sensory Organs

Institute

Department

Personal name



Funding Source

Organization

Japan Agency for Medical Research and Development

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Kyoto University Graduate School and Faculty of Medicine, Ethics Committee

Address

Yoshida-Konoe-cho, Sakyo-ku, Kyoto 606-8501, JAPAN

Tel

075-753-4680

Email

ethcom@kuhp.kyoto-u.ac.jp


Secondary IDs

Secondary IDs

YES

Study ID_1

G1207-1

Org. issuing International ID_1

Kyoto University Graduate School and Faculty of Medicine, Ethics Committee

Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2020 Year 08 Month 17 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2019 Year 09 Month 27 Day

Date of IRB

2019 Year 09 Month 27 Day

Anticipated trial start date

2019 Year 12 Month 18 Day

Last follow-up date

2040 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

In this study, we conduct follow-up survey of background information, life environments, life conditions, symptoms, therapeutic histories, etc. in patients with deafblindness with congenital or early onset.


Management information

Registered date

2020 Year 08 Month 13 Day

Last modified on

2022 Year 09 Month 06 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046395


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name